Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway

Cardiovascular Research

Volumn 72, Issue 3, 2006, Pages 456-463

  Song, Jin ^a   Kost Jr , Curtis K ^a   Martin, Douglas S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Angiotensin; Gender; Hypertension; Protein kinase; Vasoconstriction

Indexed keywords

ANDROGEN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ENZYME; FASUDIL; MYOSIN PHOSPHATASE TARGET SUBUNIT 1; RHO KINASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; ENZYME INHIBITION; HORMONE SUBSTITUTION; HYPERTENSION; KIDNEY; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; WESTERN BLOTTING;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CARRIER PROTEINS; ENALAPRIL; ENZYME ACTIVATION; HYPERTENSION, RENAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; ORCHIECTOMY; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, MUTANT STRAINS; RENAL VEINS; SIGNAL TRANSDUCTION; TESTOSTERONE; VASCULAR RESISTANCE;

EID: 33750528156     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.09.007     Document Type: Article

References (46)

1. Dubey R.K., Oparil S., Imthurn B., and Jackson E.K. Sex hormones and hypertension. Cardiovasc Res 53 (2002) 688-708
2. Reckelhoff J.F. Gender differences in the regulation of blood pressure. Hypertension 37 (2001) 1199-1208
3. Reckelhoff J.F. Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension 45 (2005) 170-174
4. Rowland N.E., and Fregly M.J. Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clin Exp Hypertens A 14 (1992) 367-375
5. Chen Y.F., and Meng Q.C. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 48 (1991) 85-96
6. Ganten U., Schroder G., Witt M., Zimmermann F., Stock D., and Stock G. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J Hypertens 7 (1989) 721-726
7. Reckelhoff J.F., Zhang H., and Granger J.P. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31 (1998) 435-439
8. Reckelhoff J.F., and Granger J.P. Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 26 (1999) 127-131
9. Ji H., Menini S., Mok K., Zheng W., Pesce C., Kim J., et al. Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol 288 (2005) F513-F520
10. Song J., Kost Jr. C.K., and Martin D.S. Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1608-R1615
11. Hall J.E. The kidney, hypertension, and obesity. Hypertension 41 (2003) 625-633
12. Grisk O., and Rettig R. Renal transplantation studies in genetic hypertension. News Physiol Sci 16 (2001) 262-265
13. Ashton N., and Balment R.J. Sexual dimorphism in renal function and hormonal status of New Zealand genetically hypertensive rats. Acta Endocrinol (Copenh) 124 (1991) 91-97
14. Touyz R.M., and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35 (2002) 1001-1015
15. Touyz R.M. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 5 (2003) 155-164
16. Cavarape A., Bauer J., Bartoli E., Endlich K., and Parekh N. Effects of angiotensin II, arginine vasopressin and thromboxane A2 in renal vascular bed: role of Rho-kinase. Nephrol Dial Transplant 18 (2003) 1764-1769
17. Somlyo A.P., and Somlyo A.V. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522 Pt 2 (2000) 177-185
18. Mukai Y., Shimokawa H., Matoba T., Kandabashi T., Satoh S., Hiroki J., et al. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 15 (2001) 1062-1064
19. Masumoto A., Hirooka Y., Shimokawa H., Hironaga K., Setoguchi S., and Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38 (2001) 1307-1310
20. Loirand G., Cario-Toumaniantz C., Chardin P., and Pacaud P. The Rho-related protein Rnd1 inhibits Ca2+ sensitization of rat smooth muscle. J Physiol 516 Pt 3 (1999) 825-834
21. Chrissobolis S., Budzyn K., Marley P.D., and Sobey C.G. Evidence that estrogen suppresses Rho-kinase function in the cerebral circulation in vivo. Stroke 35 (2004) 2200-2205
22. Guilluy C., Sauzeau V., Rolli-Derkinderen M., Guerin P., Sagan C., Pacaud P., et al. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol 146 (2005) 1010-1018
23. Moriki N., Ito M., Seko T., Kureishi Y., Okamoto R., Nakakuki T., et al. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27 (2004) 263-270
24. Lee D.L., Webb R.C., and Jin L. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension 44 (2004) 796-799
25. Reckelhoff J.F., Zhang H., Srivastava K., and Granger J.P. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34 (1999) 920-923
26. Simpson F.O., Phelan E.L., Clark D.W., Jones D.R., Gresson C.R., Lee D.R., et al. Studies on the New Zealand strain of genetically hypertensive rats. Clin Sci Mol Med Suppl 45 Suppl 1 (1973) 15s-21s
27. Simpson F.O., Ledingham J.M., and Phelan E.L. Body sodium level in hypertensive and normotensive rats: effects of dietary sodium levels and sodium loads. J Cardiovasc Pharmacol 6 Suppl 1 (1984) S121-S125
28. Hall J.E., Mizelle H.L., Hildebrandt D.A., and Brands M.W. Abnormal pressure natriuresis. A cause or a consequence of hypertension?. Hypertension 15 (1990) 547-559
29. Kost Jr. C.K., Herzer W.A., Li P., and Jackson E.K. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269 (1994) 82-88
30. Reckelhoff J.F., Zhang H., and Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 35 (2000) 480-483
31. Leung P.S., Wong T.P., Chung Y.W., and Chan H.C. Androgen dependent expression of AT1 receptor and its regulation of anion secretion in rat epididymis. Cell Biol Int 26 (2002) 117-122
32. Ogut O., and Brozovich F.V. Regulation of force in vascular smooth muscle. J Mol Cell Cardiol 35 (2003) 347-355
33. Somlyo A.P., and Somlyo A.V. Ca2+ sensitivity of smooth muscle and non-muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 (2003) 1325-1358
34. Faraci F.M., Lamping K.G., Modrick M.L., Ryan M.J., Sigmund C.D., and Didion S.P. Cerebral vascular effects of angiotensin II: new insights from genetic models. J Cereb Blood Flow Metab 26 (2006) 449-455
35. Cavarape A., Endlich N., Assaloni R., Bartoli E., Steinhausen M., Parekh N., et al. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol 14 (2003) 37-45
36. Sharpe C.C., and Hendry B.M. Signaling: focus on Rho in renal disease. J Am Soc Nephrol 14 (2003) 261-264
37. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
38. Jin L., Ying Z., Hilgers R.H., Yin J., Zhao X., Imig J.D., et al. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats. J Pharmacol Exp Ther 318 (2006) 288-295
39. Jackson E.K., Andresen B.T., Seasholtz T.M., Zhu C., and Romero G.G. Enhanced activation of RhoA by angiotensin II in SHR preglomerular microvascular smooth muscle cells. J Cardiovasc Pharmacol 45 (2005) 283-285
40. Wingard C.J., Johnson J.A., Holmes A., and Prikosh A. Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am J Physiol Regul Integr Comp Physiol 284 (2003) R1572-R1579
41. Reckelhoff J.F., Zhang H., and Granger J.P. Decline in renal hemodynamic function in aging SHR: role of androgens. Hypertension 30 (1997) 677-681
42. Ruperez M., Sanchez-Lopez E., Blanco-Colio L.M., Esteban V., Rodriguez-Vita J., Plaza J.J., et al. The Rho-kinase pathway regulates angiotensin II-induced renal damage. Kidney Int Suppl 99 (2005) S39-S45
43. Nishikimi T., Akimoto K., Wang X., Mori Y., Tadokoro K., Ishikawa Y., et al. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens 22 (2004) 1787-1796
44. Ishikawa Y., Nishikimi T., Akimoto K., Ishimura K., Ono H., and Matsuoka H. Long-term administration of Rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 47 (2006) 1075-1083
45. Sun G.P., Kohno M., Guo P., Nagai Y., Miyata K., Fan Y.Y., et al. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 17 (2006) 2193-2201
46. Hirooka Y., and Shimokawa H. Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases. Am J Cardiovasc Drugs 5 (2005) 31-39